Leading innovation for patients. Advanced Accelerator Applications develops, produces and commercializes drugs for targeted radioligand therapy and precision radioligand imaging. Our expertise is built on a more than 15-year legacy of manufacturing and commercializing a portfolio of PET and SPECT nuclear medicine imaging products for a number. NetSpot is a software tool for wireless network assessment, scanning, and surveys, analyzing Wi-Fi coverage and performance. It runs on Mac OS X 10.6+ and Windows 7-8-10 and supports 802.11n, 802.11a, 802.11b, and 802.11g wireless networks. NetSpot needs measurements if you’re going to create an accurate survey. You’ll add these manually if you’re drawing your own map or, if your map is an image file, you’ll need to provide.
What is NetSpot:
NETSPOT is a new FDA approved agent, gallium-68 dotatate, used as a Positron Emission Tomography (PET) tracer instead of radiolabeled glucose to better diagnose and treat neuroendocrine tumors.
- NETs are difficult to find at early stages because they are usually very small and can develop anywhere in the body, such as the lungs, intestines, pancreas and stomach.
- NETs don’t rapidly consume the typical glucose tracer; therefore the standard PET scans are not as effective detecting these tumors.
How does is work?
NET cells are mainly comprised of receptors for the hormone somatostatin and unlike most other cancers, they don’t consume glucose, which normally identifies the tumor. Ga-68 dotatate mimicks the hormone that binds to somatostatin and highlights the tumor on PET imaging.
- Superior imaging for earlier detection
- Less unnecessary surgery
- Improved prediction of clinical response to somatostatin receptor-mediated therapies.
- Lower effective dosage
- 2 hour vs. 24-48 hour protocol
- No bowel cleansing needed
What are the benefits for our patients?
Our providers will be better able to diagnose neuroendocrine tumors, determine the best treatment options, plan surgery, and monitor for recurrence.
Are there any specific patient guidelines?
Patients will need to discontinue short acting somatostatin analogue for 24 hours and long acting analogues for 3 weeks.
FDA Approved: Yes (First approved June 1, 2016)
Brand name: Netspot
Generic name: gallium Ga 68 dotatate
Dosage form: Injection
Company: Advanced Accelerator Applications USA, Inc.
Treatment for:Diagnosis and Investigation
Netspot (gallium Ga 68 dotatate) is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors
Netspot Neuroendocrine
Development Timeline for Netspot
Netspot Package Insert
| Date | Article |
|---|---|
| Jun 1, 2016 | ApprovalFDA Approves Netspot (gallium Ga 68 dotatate) Imaging Agent to Detect Rare Neuroendocrine Tumors |
See Also
Further information
Netspot Wifi Analyzer
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.